The use of recombinant human epidermal growth factor (rhEGF) in a gentleman with drug-induced Steven Johnson syndrome

Dermatol Online J. 2004 Jul 15;10(1):25.

Abstract

A case of drug-induced Steven Johnson syndrome in a gentleman is reported. Its course of treatment with rhEGF was compared to conventional treatment in historical control.

Publication types

  • Case Reports
  • Letter
  • Review

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Aged
  • Anti-Inflammatory Agents / therapeutic use
  • Deglutition Disorders / etiology
  • Epidermal Growth Factor / administration & dosage
  • Epidermal Growth Factor / therapeutic use*
  • Fluid Therapy
  • Gout / drug therapy
  • Hong Kong / epidemiology
  • Humans
  • Male
  • Mefenamic Acid / adverse effects
  • Mefenamic Acid / therapeutic use
  • Ointments
  • Photophobia / etiology
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / therapeutic use
  • Retrospective Studies
  • Stevens-Johnson Syndrome / chemically induced
  • Stevens-Johnson Syndrome / drug therapy*
  • Stevens-Johnson Syndrome / epidemiology

Substances

  • Adrenal Cortex Hormones
  • Anti-Inflammatory Agents
  • Ointments
  • Recombinant Proteins
  • Mefenamic Acid
  • Epidermal Growth Factor